These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 19740409

  • 1. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Papavassiliu T, Germans T, Flüchter S, Doesch C, Suriyakamar A, Haghi D, Süselbeck T, Wolpert C, Dinter D, Schoenberg SO, van Rossum AC, Borggrefe M.
    J Cardiovasc Magn Reson; 2009 Sep 09; 11(1):34. PubMed ID: 19740409
    [Abstract] [Full Text] [Related]

  • 2. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR, Nguyen VQ, Peters DC, Soufer A, Henry ML, Grunseich K, Testani J, Hur DJ, Huber S, Mojibian H, Dicks D, Sinusas AJ, Meadows JL, Papoutsidakis N, Jacoby D, Baldassarre LA.
    Int J Cardiovasc Imaging; 2019 Jul 09; 35(7):1309-1318. PubMed ID: 30790116
    [Abstract] [Full Text] [Related]

  • 3. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
    Zhu Y, Park EA, Lee W, Kim HK, Chu A, Chung JW, Park JH.
    Eur Radiol; 2015 Apr 09; 25(4):1190-200. PubMed ID: 25597022
    [Abstract] [Full Text] [Related]

  • 4. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
    Kim KJ, Choi HM, Yoon YE, Kim HL, Lee SP, Kim HK, Kim YJ, Cho GY, Zo JH, Sohn DW.
    PLoS One; 2016 Apr 09; 11(6):e0157433. PubMed ID: 27336444
    [Abstract] [Full Text] [Related]

  • 5. Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.
    Tian H, Cui J, Yang C, Hu F, Yuan J, Liu S, Yang W, Jiang X, Qiao S.
    BMC Cardiovasc Disord; 2018 Nov 03; 18(1):207. PubMed ID: 30390664
    [Abstract] [Full Text] [Related]

  • 6. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A, Hindieh W, Spears DA, Adler A, Rakowski H, Chan RH.
    J Cardiovasc Electrophysiol; 2019 May 03; 30(5):651-657. PubMed ID: 30680853
    [Abstract] [Full Text] [Related]

  • 7. Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.
    Sivalokanathan S, Zghaib T, Greenland GV, Vasquez N, Kudchadkar SM, Kontari E, Lu DY, Dolores-Cerna K, van der Geest RJ, Kamel IR, Olgin JE, Abraham TP, Nazarian S, Zimmerman SL, Abraham MR.
    JACC Clin Electrophysiol; 2019 Mar 03; 5(3):364-375. PubMed ID: 30898240
    [Abstract] [Full Text] [Related]

  • 8. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM, Kim KH, Lee JM, Yoon YE, Lee SP, Park EA, Lee W, Kim YJ, Cho GY, Sohn DW, Kim HK.
    Heart; 2015 Jun 03; 101(11):870-6. PubMed ID: 25897040
    [Abstract] [Full Text] [Related]

  • 9. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG.
    Circ Cardiovasc Imaging; 2014 Jan 03; 7(1):11-9. PubMed ID: 24275954
    [Abstract] [Full Text] [Related]

  • 10. Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
    Hollowell M, Banno J, Marsy D, Shrestha N, Tan J, McNamara R, Decker J, Albano A, Franey L, Abdallah W, Loyaga-Rendon R, Chalfoun N, Fermin D.
    Int J Cardiol; 2024 Sep 15; 411():132263. PubMed ID: 38878873
    [Abstract] [Full Text] [Related]

  • 11. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
    Cochet H, Morlon L, Vergé MP, Salel M, Camaioni C, Reynaud A, Peyrou J, Ritter P, Jais P, Laurent F, Lafitte S, Montaudon M, Réant P.
    Arch Cardiovasc Dis; 2018 Oct 15; 111(10):591-600. PubMed ID: 29884599
    [Abstract] [Full Text] [Related]

  • 12. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
    Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ.
    J Cardiovasc Magn Reson; 2012 Oct 29; 14(1):76. PubMed ID: 23107451
    [Abstract] [Full Text] [Related]

  • 13. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT, Silva Vieira M, Kutty S, Lotz J, Hasenfu G, Chiribiri A, Schuster A.
    Invest Radiol; 2017 Mar 29; 52(3):177-185. PubMed ID: 27741021
    [Abstract] [Full Text] [Related]

  • 14. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G, Muser D, Gianfagna P, Morocutti G, Proclemer A.
    Int J Cardiovasc Imaging; 2015 Dec 29; 31(8):1603-10. PubMed ID: 26210792
    [Abstract] [Full Text] [Related]

  • 15. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P, Klimeczek P, Vliegenthart R, Pasowicz M, Miszalski-Jamka T, Oudkerk M, Podolec P, Dubiel JS, Tracz W.
    Kardiol Pol; 2009 Aug 29; 67(8A):964-9. PubMed ID: 19784900
    [Abstract] [Full Text] [Related]

  • 16. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
    Germans T, Rüssel IK, Götte MJ, Spreeuwenberg MD, Doevendans PA, Pinto YM, van der Geest RJ, van der Velden J, Wilde AA, van Rossum AC.
    J Cardiovasc Magn Reson; 2010 Mar 15; 12(1):13. PubMed ID: 20230637
    [Abstract] [Full Text] [Related]

  • 17. Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Elmas E, Doesch C, Fluechter S, Freundt M, Weiss C, Lang S, Kälsch T, Haghi D, Papassotiriou J, Kunde J, Schoenberg SO, Borggrefe M, Papavassiliu T.
    Int J Cardiovasc Imaging; 2011 Apr 15; 27(4):547-56. PubMed ID: 20872251
    [Abstract] [Full Text] [Related]

  • 18. The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
    Chen X, Zhao T, Lu M, Yin G, Xiangli W, Jiang S, Prasad S, Zhao S.
    Int J Cardiovasc Imaging; 2014 Jun 15; 30 Suppl 1():55-63. PubMed ID: 24723003
    [Abstract] [Full Text] [Related]

  • 19. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
    Ozden O, Unlu S, Kilic DI, Sherif SA, Opan S, Kemal HS, Ozmen E, Tuner H, Bingol G, Barutcu A, Nasifov M, Bakan S, Goktekin O.
    Kardiologiia; 2023 Feb 28; 63(2):52-58. PubMed ID: 36880144
    [Abstract] [Full Text] [Related]

  • 20. Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance.
    Quail M, Grunseich K, Baldassarre LA, Mojibian H, Marieb MA, Cornfeld D, Soufer A, Sinusas AJ, Peters DC.
    J Cardiovasc Magn Reson; 2019 Jan 03; 21(1):2. PubMed ID: 30602395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.